Patents by Inventor Sandra ROST

Sandra ROST has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cancer treatment with c-met antagonists and correlation of the latter with HGF expression
    Patent number: 10240207
    Abstract: The present invention concerns cancer biomarkers. In particular, the invention concerns HGF as a biomarker for patient selection and patient prognosis in cancer, as well as methods of therapeutic treatment, articles of manufacture and methods for making them, diagnostic kits, methods of detection and methods of advertising related thereto.
    Type: Grant
    Filed: September 21, 2016
    Date of Patent: March 26, 2019
    Assignee: Genentech, Inc.
    Inventors: Wei Yu, David Shames, Hartmut Koeppen, See Phan, Sandra Rost
  • CANCER TREATMENT WITH C-MET ANTAGONISTS AND CORRELATION OF THE LATTER WITH HGF EXPRESSION
    Publication number: 20170183740
    Abstract: The present invention concerns cancer biomarkers. In particular, the invention concerns HGF as a biomarker for patient selection and patient prognosis in cancer, as well as methods of therapeutic treatment, articles of manufacture and methods for making them, diagnostic kits, methods of detection and methods of advertising related thereto.
    Type: Application
    Filed: September 21, 2016
    Publication date: June 29, 2017
    Applicant: Genentech, Inc.
    Inventors: Wei YU, David SHAMES, Hartmut KOEPPEN, See PHAN, Sandra ROST